BODY SHIELD

BODY SHIELD was reported 695 times

BODY SHIELD is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CRANIOLACUNIA 1 0.5000
1 ANGIOSCOPY 2 0.4000
2 PSEUDOHYPOPYON 4 0.3333
3 LACRIMAL CYST 1 0.1250
4 BREVIBACTERIUM INFECTION 1 0.1111
5 CARBOHYDRATE ANTIGEN 15-3 3 0.1000
6 GASTRIC RESIDUAL INCREASED 1 0.0345
7 HER2 POSITIVE GASTRIC CANCER 1 0.0312
8 JOINT DEFORMITY 2 0.0267
9 BULBOSPINAL MUSCULAR ATROPHY CONGENITAL 1 0.0233
10 CARDIAC COMPLICATION ASSOCIATED WITH DEVICE 1 0.0227
11 APHAKIA 1 0.0213
12 FEMORAL ARTERY EMBOLISM 1 0.0169
13 GLOMERULONEPHRITIS CHRONIC 3 0.0160
14 GASTROINTESTINAL NEUROENDOCRINE TUMOUR 1 0.0154
15 BORDERLINE OVARIAN TUMOUR 1 0.0149
16 LIVER PALPABLE 1 0.0141
17 ATHEROSCLEROTIC PLAQUE RUPTURE 1 0.0137
18 UNEVALUABLE INVESTIGATION 2 0.0120
19 CORYNEBACTERIUM BACTERAEMIA 1 0.0118
20 APPLICATION SITE ECZEMA 1 0.0115
21 BLOOD IMMUNOGLOBULIN E ABNORMAL 1 0.0110
22 AMOEBIC COLITIS 1 0.0110
23 EXAGGERATED STARTLE RESPONSE 2 0.0109
24 GASTROINTESTINAL TRACT MUCOSAL DISCOLOURATION 1 0.0104
25 BLOOD CORTICOTROPHIN ABNORMAL 1 0.0104
26 DUODENAL NEOPLASM 1 0.0102
27 ANAL POLYP 1 0.0097
28 ANAL EROSION 1 0.0091
29 ABDOMINAL WALL CYST 1 0.0082
30 CHRONIC DISEASE 2 0.0078
31 PALPABLE PURPURA 2 0.0073
32 HYPERVITAMINOSIS 1 0.0072
33 GASTROINTESTINAL ISCHAEMIA 2 0.0072
34 BLADDER DIVERTICULUM 1 0.0063
35 TUMOUR MARKER ABNORMAL 2 0.0060
36 DIASTOLIC HYPOTENSION 1 0.0059
37 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
38 TYPE III IMMUNE COMPLEX MEDIATED REACTION 3 0.0054
39 BENIGN PANCREATIC NEOPLASM 1 0.0053
40 FAMILIAL MEDITERRANEAN FEVER 1 0.0051
41 CORTISOL ABNORMAL 1 0.0050
42 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
43 IMMOBILISATION SYNDROME 1 0.0047
44 HEPATIC ATROPHY 2 0.0045
45 IMMUNE-MEDIATED HYPOPHYSITIS 2 0.0044
46 CONGENITAL HIATUS HERNIA 1 0.0044
47 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
48 EUSTACHIAN TUBE DISORDER 1 0.0042
49 SYSTEMIC SCLERODERMA 3 0.0041
50 FOREIGN BODY REACTION 1 0.0041
51 HYPERCALCIURIA 2 0.0041
52 DRUG LABEL CONFUSION 1 0.0040
53 ANAL INFECTION 1 0.0039
54 HYPERMETABOLISM 2 0.0038
55 BACTERIAL ENDOPHTHALMITIS 1 0.0038
56 LIMB TRAUMATIC AMPUTATION 1 0.0037
57 DYSBIOSIS 3 0.0037
58 APPLICATION SITE MASS 1 0.0036
59 HYPERADRENOCORTICISM 1 0.0036
60 CARBUNCLE 1 0.0035
61 DERMATOPHYTOSIS 1 0.0035
62 CARDIO-RESPIRATORY DISTRESS 1 0.0035
63 URINARY TRACT INFECTION FUNGAL 2 0.0035
64 VASCULAR DEMENTIA 3 0.0034
65 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
66 ENTEROCOLITIS VIRAL 1 0.0033
67 BOWEL SOUNDS ABNORMAL 1 0.0032
68 COLORECTAL ADENOMA 1 0.0031
69 GASTROENTERITIS RADIATION 1 0.0030
70 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
71 LOW CARDIAC OUTPUT SYNDROME 1 0.0030
72 CHOLURIA 1 0.0029
73 SCEDOSPORIUM INFECTION 2 0.0028
74 FEEDING TUBE USER 1 0.0027
75 HYPOPROTEINAEMIA 5 0.0026
76 ACUTE PHASE REACTION 1 0.0026
77 ALKALOSIS 1 0.0026
78 LIPID METABOLISM DISORDER 1 0.0026
79 ASPIRATION PLEURAL CAVITY 2 0.0026
80 APPENDICOLITH 1 0.0026
81 MYCOPLASMA INFECTION 2 0.0026
82 BLUE TOE SYNDROME 1 0.0026
83 DEVICE COLOUR ISSUE 1 0.0025
84 HYPOTONY OF EYE 1 0.0024
85 BLOOD MAGNESIUM INCREASED 2 0.0022
86 LAPAROTOMY 1 0.0022
87 GALLBLADDER RUPTURE 1 0.0022
88 VOLVULUS 5 0.0021
89 KERATIC PRECIPITATES 1 0.0021
90 APPLICATION SITE ACNE 1 0.0020
91 AUTOIMMUNE PANCREATITIS 1 0.0020
92 ACCIDENT AT HOME 1 0.0019
93 FAECAL VOMITING 1 0.0019
94 CORYNEBACTERIUM INFECTION 1 0.0019
95 TRAUMATIC HAEMATOMA 2 0.0019
96 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
97 HYPERTROPHY 1 0.0018
98 PNEUMONIA STREPTOCOCCAL 2 0.0018
99 HAEMORRHAGIC INFARCTION 1 0.0018
100 BACTERIAL TEST POSITIVE 4 0.0018
101 ENCEPHALOMALACIA 1 0.0018
102 APNOEIC ATTACK 1 0.0018
103 MACROCYTOSIS 2 0.0017
104 DISCOURAGEMENT 4 0.0017
105 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
106 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
107 GASTROINTESTINAL POLYP HAEMORRHAGE 1 0.0017
108 FAT NECROSIS 1 0.0016
109 GASTROINTESTINAL EROSION 1 0.0016
110 LARYNGEAL DISCOMFORT 1 0.0016
111 ILEUS PARALYTIC 7 0.0016
112 ANAL INFLAMMATION 1 0.0016
113 EXTREMITY CONTRACTURE 1 0.0016
114 TRAUMATIC LUNG INJURY 3 0.0016
115 MESOTHELIOMA 2 0.0015
116 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
117 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
118 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
119 INTESTINAL DILATATION 2 0.0015
120 BRONCHITIS VIRAL 1 0.0015
121 LEIOMYOMA 1 0.0014
122 DERMATITIS DIAPER 1 0.0014
123 BRONCHIAL WALL THICKENING 1 0.0014
124 LARYNGEAL DISORDER 1 0.0014
125 SEBORRHOEIC KERATOSIS 2 0.0014
126 GASTRIC MUCOSAL LESION 1 0.0014
127 GASTROINTESTINAL NECROSIS 4 0.0014
128 STOMA SITE PAIN 2 0.0014
129 LEGAL PROBLEM 1 0.0014
130 PNEUMONIA PNEUMOCOCCAL 2 0.0013
131 BLISTER RUPTURE 1 0.0013
132 EOSINOPHIL COUNT ABNORMAL 1 0.0013
133 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
134 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
135 MEGACOLON 2 0.0013
136 ANTICHOLINERGIC SYNDROME 2 0.0013
137 EXCESSIVE GRANULATION TISSUE 1 0.0012
138 INTESTINAL POLYP 2 0.0012
139 TROPONIN I INCREASED 2 0.0012
140 VEIN RUPTURE 2 0.0012
141 EROSIVE OESOPHAGITIS 2 0.0012
142 GAZE PALSY 2 0.0012
143 ACUTE SINUSITIS 2 0.0012
144 ENTEROVIRUS INFECTION 1 0.0012
145 GENITAL BURNING SENSATION 1 0.0012
146 ENDOCRINE OPHTHALMOPATHY 1 0.0012
147 FOOD REFUSAL 1 0.0011
148 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
149 INFUSION SITE DISCOLOURATION 1 0.0011
150 GASTRIC PERFORATION 3 0.0011
151 CERUMEN IMPACTION 1 0.0011
152 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
153 CATHETER SITE SWELLING 1 0.0011
154 STENOSIS 2 0.0011
155 CYSTOID MACULAR OEDEMA 2 0.0011
156 HEPATIC CONGESTION 1 0.0011
157 INTUSSUSCEPTION 1 0.0010
158 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
159 BUTTERFLY RASH 1 0.0010
160 IMMUNE-MEDIATED HEPATITIS 2 0.0010
161 BRAIN STEM INFARCTION 1 0.0010
162 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
163 HYDROCELE 1 0.0009
164 HAEMOGLOBIN ABNORMAL 6 0.0009
165 BLOOD TESTOSTERONE INCREASED 2 0.0009
166 SPUTUM INCREASED 2 0.0009
167 SUSPECTED COVID-19 3 0.0009
168 NOSOCOMIAL INFECTION 2 0.0009
169 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
170 CARDIAC HYPERTROPHY 1 0.0009
171 SPINAL COLUMN INJURY 2 0.0009
172 CATHETER SITE DISCHARGE 1 0.0009
173 CHRONIC GASTRITIS 2 0.0009
174 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
175 BLADDER OPERATION 1 0.0009
176 INTRUSIVE THOUGHTS 1 0.0008
177 PULMONARY INFARCTION 2 0.0008
178 PANCREATITIS CHRONIC 2 0.0008
179 COLORECTAL CANCER METASTATIC 2 0.0008
180 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
181 HAEMATOMA MUSCLE 1 0.0008
182 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
183 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
184 CUTANEOUS VASCULITIS 3 0.0008
185 IMMUNE-MEDIATED ENTEROCOLITIS 3 0.0008
186 DERMAL CYST 2 0.0008
187 HAEMATOCRIT ABNORMAL 1 0.0008
188 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
189 ILEUS 10 0.0008
190 BREECH PRESENTATION 1 0.0008
191 FACE INJURY 3 0.0008
192 ASPERGILLOSIS 1 0.0008
193 PSYCHOMOTOR SKILLS IMPAIRED 2 0.0008
194 GLYCOSURIA 1 0.0007
195 ACCIDENTAL POISONING 1 0.0007
196 TENOSYNOVITIS 2 0.0007
197 CHRONIC FATIGUE SYNDROME 1 0.0007
198 CARDIOVERSION 1 0.0007
199 ACUTE PULMONARY OEDEMA 4 0.0007
200 BRONCHIAL OBSTRUCTION 1 0.0007
201 SKIN HYPERTROPHY 2 0.0007
202 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
203 LOW DENSITY LIPOPROTEIN DECREASED 1 0.0007
204 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
205 LUNG CANCER METASTATIC 2 0.0007
206 VITAMIN B12 DECREASED 2 0.0007
207 DIVERTICULUM INTESTINAL 3 0.0007
208 HEPATITIS FULMINANT 2 0.0007
209 RHEUMATIC FEVER 3 0.0007
210 ADHESION 1 0.0007
211 INFECTIOUS PLEURAL EFFUSION 1 0.0007
212 GENITAL HERPES 1 0.0007
213 CALCULUS URINARY 1 0.0006
214 GASTROSTOMY 1 0.0006
215 FUNGAEMIA 1 0.0006
216 ABDOMINAL ADHESIONS 2 0.0006
217 INTESTINAL ULCER 1 0.0006
218 MALNUTRITION 7 0.0006
219 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
220 BRADYARRHYTHMIA 1 0.0006
221 GASTRITIS 16 0.0006
222 COLONIC POLYP 1 0.0006
223 PEPTIC ULCER 2 0.0006
224 ANTIBODY TEST POSITIVE 1 0.0006
225 HYPERNATRAEMIA 3 0.0006
226 ANXIETY DISORDER 2 0.0006
227 EXPOSURE TO CHEMICAL POLLUTION 1 0.0006
228 TONGUE ULCERATION 2 0.0006
229 PATHOLOGICAL FRACTURE 3 0.0006
230 ECCHYMOSIS 4 0.0006
231 VARICOSE VEIN 3 0.0006
232 THROMBOPHLEBITIS 2 0.0006
233 BURNS SECOND DEGREE 1 0.0006
234 BRONCHIOLITIS 2 0.0006
235 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
236 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
237 HAEMORRHAGIC DIATHESIS 2 0.0006
238 DEVICE ALARM ISSUE 1 0.0006
239 HYDROCEPHALUS 3 0.0006
240 INTESTINAL ISCHAEMIA 3 0.0005
241 BODY TEMPERATURE ABNORMAL 1 0.0005
242 LYMPH NODE PAIN 1 0.0005
243 BLOOD CHOLESTEROL DECREASED 1 0.0005
244 AURA 1 0.0005
245 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
246 OESOPHAGEAL ULCER 2 0.0005
247 HEPATIC MASS 1 0.0005
248 ARTERIAL THROMBOSIS 1 0.0005
249 ATROPHY 1 0.0005
250 EARLY SATIETY 1 0.0005
251 COLOSTOMY 1 0.0005
252 RENAL CYST 4 0.0005
253 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
254 CARDIAC DISCOMFORT 1 0.0005
255 CHOLANGITIS 3 0.0005
256 CAPILLARY LEAK SYNDROME 1 0.0005
257 INTERNATIONAL NORMALISED RATIO FLUCTUATION 1 0.0005
258 GASTROENTERITIS 7 0.0005
259 DEVICE CONNECTION ISSUE 1 0.0005
260 EAR SWELLING 1 0.0005
261 HEPATIC NEOPLASM MALIGNANT 1 0.0005
262 CARDIAC FAILURE CHRONIC 2 0.0005
263 CATHETER SITE ERYTHEMA 1 0.0005
264 IRRITABLE BOWEL SYNDROME 10 0.0005
265 HYPERPHOSPHATAEMIA 1 0.0005
266 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
267 DEVICE RELATED INFECTION 7 0.0005
268 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
269 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
270 BLOOD CREATINE INCREASED 2 0.0005
271 CARDIAC FAILURE ACUTE 3 0.0004
272 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
273 GASTRIC POLYPS 1 0.0004
274 DISTRIBUTIVE SHOCK 1 0.0004
275 VASCULAR DEVICE INFECTION 2 0.0004
276 DISEASE COMPLICATION 2 0.0004
277 DENGUE FEVER 1 0.0004
278 LARGE INTESTINE POLYP 3 0.0004
279 LOCALISED OEDEMA 2 0.0004
280 INFUSION SITE INFECTION 1 0.0004
281 HEPATIC ENCEPHALOPATHY 4 0.0004
282 BILIRUBIN CONJUGATED INCREASED 1 0.0004
283 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
284 BLOOD PROLACTIN INCREASED 2 0.0004
285 EOSINOPHIL COUNT DECREASED 1 0.0004
286 SUBCUTANEOUS ABSCESS 2 0.0004
287 GASTROINTESTINAL OBSTRUCTION 1 0.0004
288 VISUAL FIELD DEFECT 3 0.0004
289 ATELECTASIS 4 0.0004
290 MOUTH HAEMORRHAGE 3 0.0004
291 RENAL TUBULAR NECROSIS 4 0.0004
292 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
293 PNEUMONIA ASPIRATION 10 0.0004
294 HYPERAMMONAEMIA 2 0.0004
295 CATHETER SITE HAEMORRHAGE 1 0.0004
296 HEPATIC FAILURE 12 0.0004
297 PAROSMIA 3 0.0004
298 LABYRINTHITIS 1 0.0004
299 KLEBSIELLA INFECTION 2 0.0004
300 INCREASED BRONCHIAL SECRETION 1 0.0004
301 ABNORMAL UTERINE BLEEDING 1 0.0004
302 AORTIC ARTERIOSCLEROSIS 1 0.0004
303 DRUG TITRATION ERROR 1 0.0004
304 CATHETER SITE PAIN 1 0.0004
305 MALABSORPTION 2 0.0004
306 PRODUCT USE COMPLAINT 6 0.0004
307 LUNG OPACITY 1 0.0004
308 ATRIAL FLUTTER 3 0.0004
309 BLOOD POTASSIUM ABNORMAL 1 0.0004
310 ASCITES 11 0.0004
311 FOOD POISONING 2 0.0004
312 MYASTHENIA GRAVIS 3 0.0004
313 LARGE INTESTINAL ULCER 1 0.0004
314 BLOOD PHOSPHORUS INCREASED 1 0.0004
315 ASPIRATION 4 0.0004
316 SPINAL COMPRESSION FRACTURE 3 0.0004
317 ERUCTATION 7 0.0004
318 EOSINOPHILIC OESOPHAGITIS 1 0.0004
319 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
320 ELECTRIC SHOCK SENSATION 1 0.0004
321 DRUG TOLERANCE DECREASED 1 0.0004
322 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
323 PSEUDOMONAS INFECTION 3 0.0003
324 DUODENAL ULCER HAEMORRHAGE 1 0.0003
325 ANURIA 3 0.0003
326 HYPOGLYCAEMIC COMA 1 0.0003
327 ENTEROCOLITIS 2 0.0003
328 BLOOD URIC ACID INCREASED 2 0.0003
329 HYPERTONIC BLADDER 1 0.0003
330 ELECTROLYTE IMBALANCE 4 0.0003
331 LUMBAR SPINAL STENOSIS 1 0.0003
332 HYPERKALAEMIA 12 0.0003
333 HYPERLIPIDAEMIA 4 0.0003
334 ENDOPHTHALMITIS 2 0.0003
335 HYPERCAPNIA 1 0.0003
336 CEREBROVASCULAR DISORDER 1 0.0003
337 CENTRAL VENOUS CATHETERISATION 1 0.0003
338 LOSS OF EMPLOYMENT 1 0.0003
339 BONE MARROW DISORDER 1 0.0003
340 EYE INJURY 1 0.0003
341 DYSCHEZIA 1 0.0003
342 PNEUMONIA BACTERIAL 3 0.0003
343 IRON DEFICIENCY ANAEMIA 3 0.0003
344 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
345 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
346 OLIGURIA 2 0.0003
347 BLOOD CREATININE DECREASED 1 0.0003
348 SWELLING OF EYELID 2 0.0003
349 MULTIPLE INJURIES 2 0.0003
350 BREAST CANCER RECURRENT 1 0.0003
351 ULCER 5 0.0003
352 LOOSE TOOTH 1 0.0003
353 LIVER ABSCESS 1 0.0003
354 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
355 HEPATIC NEOPLASM 1 0.0003
356 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
357 CHOLELITHIASIS 10 0.0003
358 HYPOGAMMAGLOBULINAEMIA 2 0.0003
359 INJECTION SITE INFECTION 1 0.0003
360 DEAFNESS NEUROSENSORY 1 0.0003
361 APPETITE DISORDER 2 0.0003
362 SEPTIC SHOCK 13 0.0003
363 EMPHYSEMA 3 0.0003
364 HEPATIC CYST 1 0.0003
365 IMPAIRED GASTRIC EMPTYING 4 0.0003
366 EYE MOVEMENT DISORDER 2 0.0003
367 CERVICAL VERTEBRAL FRACTURE 1 0.0003
368 GRANULOMA 1 0.0003
369 HYPOPNOEA 1 0.0003
370 LARGE INTESTINE PERFORATION 2 0.0003
371 AUTOIMMUNE HEPATITIS 2 0.0003
372 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
373 PETECHIAE 3 0.0003
374 RIGHT VENTRICULAR FAILURE 2 0.0003
375 HANGOVER 1 0.0003
376 PULMONARY TOXICITY 2 0.0003
377 FLATULENCE 16 0.0003
378 THERMAL BURN 2 0.0003
379 ABDOMINAL DISTENSION 29 0.0003
380 RASH PUSTULAR 2 0.0003
381 FOOD INTOLERANCE 1 0.0003
382 SENSITIVE SKIN 2 0.0003
383 HYPOPHOSPHATAEMIA 2 0.0003
384 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
385 IMMUNODEFICIENCY 4 0.0003
386 SKIN INFECTION 3 0.0003
387 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
388 AUTOIMMUNE THYROIDITIS 1 0.0003
389 CATHETER SITE INFECTION 1 0.0003
390 TROPONIN INCREASED 2 0.0003
391 GASTRIC INFECTION 1 0.0003
392 CLAVICLE FRACTURE 1 0.0003
393 DISSOCIATION 2 0.0003
394 PROCEDURAL COMPLICATION 2 0.0003
395 RESPIRATORY FAILURE 19 0.0003
396 RENAL FAILURE CHRONIC 2 0.0003
397 HYPOKALAEMIA 12 0.0003
398 GASTROINTESTINAL INFLAMMATION 2 0.0003
399 CHOLECYSTITIS 3 0.0003
400 PRESCRIBED UNDERDOSE 5 0.0003
401 AZOTAEMIA 1 0.0003
402 RHINITIS 2 0.0002
403 HYPOGLYCAEMIA 12 0.0002
404 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
405 DECUBITUS ULCER 2 0.0002
406 CYTOPENIA 3 0.0002
407 ASPHYXIA 2 0.0002
408 CARDIOMEGALY 3 0.0002
409 HICCUPS 2 0.0002
410 HYPERURICAEMIA 1 0.0002
411 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1 0.0002
412 GASTROINTESTINAL PERFORATION 1 0.0002
413 INJECTION SITE DISCOLOURATION 3 0.0002
414 INTESTINAL OBSTRUCTION 9 0.0002
415 DERMATITIS ALLERGIC 3 0.0002
416 ABDOMINAL PAIN 55 0.0002
417 BUNDLE BRANCH BLOCK LEFT 1 0.0002
418 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
419 EATING DISORDER 5 0.0002
420 INTERVERTEBRAL DISC DISORDER 1 0.0002
421 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
422 GENITAL HAEMORRHAGE 3 0.0002
423 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
424 HYSTERECTOMY 2 0.0002
425 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
426 IMMOBILE 1 0.0002
427 METASTASES TO LIVER 4 0.0002
428 SARS-COV-2 TEST POSITIVE 3 0.0002
429 LUNG INFILTRATION 2 0.0002
430 ABDOMINAL ABSCESS 1 0.0002
431 PURPURA 2 0.0002
432 DRUG ERUPTION 4 0.0002
433 PANCREATITIS ACUTE 5 0.0002
434 OROPHARYNGEAL DISCOMFORT 2 0.0002
435 LIMB INJURY 6 0.0002
436 HYPERGLYCAEMIA 8 0.0002
437 ACUTE HEPATIC FAILURE 3 0.0002
438 PERIPHERAL COLDNESS 3 0.0002
439 IMMUNE THROMBOCYTOPENIA 1 0.0002
440 SHOCK 5 0.0002
441 PERICARDIAL EFFUSION 5 0.0002
442 HYPOMAGNESAEMIA 3 0.0002
443 FEELING OF DESPAIR 1 0.0002
444 HEPATIC FUNCTION ABNORMAL 8 0.0002
445 NEPHROPATHY 2 0.0002
446 APPENDICITIS 2 0.0002
447 FLANK PAIN 2 0.0002
448 SPINAL DISORDER 2 0.0002
449 SPUTUM DISCOLOURED 2 0.0002
450 ENDOMETRIOSIS 1 0.0002
451 CHOLESTASIS 4 0.0002
452 HYPERTHYROIDISM 3 0.0002
453 ENTEROCOCCAL INFECTION 1 0.0002
454 INTERSTITIAL LUNG DISEASE 10 0.0002
455 LIVER FUNCTION TEST ABNORMAL 6 0.0002
456 AUTOIMMUNE DISORDER 2 0.0002
457 VITAMIN D DEFICIENCY 2 0.0002
458 HEPATOMEGALY 2 0.0002
459 BREATH SOUNDS ABNORMAL 1 0.0002
460 PULMONARY MASS 3 0.0002
461 RESPIRATORY DISORDER 6 0.0002
462 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
463 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
464 SEPSIS 22 0.0002
465 FEEDING DISORDER 4 0.0002
466 PLEURAL EFFUSION 12 0.0002
467 NEUTROPHIL COUNT DECREASED 8 0.0002
468 FEBRILE NEUTROPENIA 13 0.0002
469 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
470 CEREBRAL ISCHAEMIA 1 0.0002
471 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
472 SKELETAL INJURY 2 0.0002
473 PERITONITIS 4 0.0002
474 HYPERBILIRUBINAEMIA 2 0.0002
475 WEIGHT FLUCTUATION 2 0.0002
476 CYANOSIS 3 0.0002
477 PNEUMOTHORAX 3 0.0002
478 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
479 COMPRESSION FRACTURE 1 0.0002
480 ANAL FISSURE 1 0.0002
481 BREAST CANCER METASTATIC 2 0.0002
482 NIGHT SWEATS 6 0.0002
483 INTESTINAL RESECTION 1 0.0002
484 ANAL ABSCESS 1 0.0002
485 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
486 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
487 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
488 INJECTION SITE INJURY 1 0.0002
489 STEVENS-JOHNSON SYNDROME 4 0.0002
490 TRANSAMINASES INCREASED 4 0.0002
491 FEELING COLD 5 0.0002
492 HEART RATE ABNORMAL 1 0.0002
493 HAEMOPTYSIS 5 0.0002
494 WOUND 5 0.0002
495 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
496 INTESTINAL PERFORATION 2 0.0002
497 REBOUND EFFECT 2 0.0002
498 CHOLECYSTITIS ACUTE 1 0.0002
499 PRODUCT AVAILABILITY ISSUE 4 0.0002
500 INTENTIONAL DOSE OMISSION 5 0.0002
501 NEOPLASM 2 0.0002
502 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
503 GASTRIC HAEMORRHAGE 2 0.0002
504 VASCULITIS 2 0.0002
505 HYPERTRIGLYCERIDAEMIA 1 0.0002
506 SPLENOMEGALY 2 0.0002
507 HYPOXIA 6 0.0002
508 PANCREATITIS 9 0.0002
509 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
510 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
511 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
512 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
513 BACTERAEMIA 2 0.0002
514 THIRST 3 0.0002
515 RHABDOMYOLYSIS 7 0.0002
516 CARDIAC PACEMAKER INSERTION 1 0.0002
517 GANGRENE 1 0.0002
518 LEUKOCYTOSIS 3 0.0002
519 TOOTHACHE 3 0.0002
520 C-REACTIVE PROTEIN INCREASED 6 0.0002
521 BURSITIS 2 0.0002
522 INGUINAL HERNIA 1 0.0002
523 HAEMATOCHEZIA 9 0.0002
524 LIVER INJURY 4 0.0002
525 GENERALISED OEDEMA 2 0.0002
526 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
527 HYPONATRAEMIA 9 0.0002
528 SECRETION DISCHARGE 2 0.0002
529 DRUG-INDUCED LIVER INJURY 5 0.0002
530 DECREASED APPETITE 37 0.0002
531 DYSPNOEA EXERTIONAL 6 0.0002
532 INFUSION SITE SWELLING 1 0.0002
533 COLITIS 6 0.0002
534 MUSCLE ATROPHY 2 0.0002
535 LIVER DISORDER 7 0.0002
536 PULMONARY OEDEMA 7 0.0002
537 POST PROCEDURAL COMPLICATION 3 0.0002
538 GLAUCOMA 3 0.0002
539 MOVEMENT DISORDER 5 0.0002
540 PRESCRIBED OVERDOSE 3 0.0002
541 HEPATITIS ACUTE 1 0.0002
542 RESPIRATORY TRACT INFECTION 4 0.0002
543 SPEECH DISORDER 8 0.0002
544 ASPERGILLUS INFECTION 1 0.0002
545 BEDRIDDEN 2 0.0002
546 TOOTH INFECTION 2 0.0002
547 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
548 CORONAVIRUS INFECTION 1 0.0002
549 BLOOD PRESSURE ABNORMAL 3 0.0002
550 URINARY RETENTION 5 0.0001
551 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
552 BREAST MASS 1 0.0001
553 JAUNDICE 4 0.0001
554 OEDEMA 8 0.0001
555 TACHYPNOEA 2 0.0001
556 BODY TEMPERATURE INCREASED 3 0.0001
557 ABNORMAL LOSS OF WEIGHT 1 0.0001
558 SKIN LESION 4 0.0001
559 HAIR GROWTH ABNORMAL 1 0.0001
560 BLOOD TEST ABNORMAL 2 0.0001
561 PYREXIA 49 0.0001
562 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
563 HAND FRACTURE 1 0.0001
564 HEPATOCELLULAR INJURY 2 0.0001
565 DRY EYE 7 0.0001
566 FEAR OF INJECTION 1 0.0001
567 ANGINA PECTORIS 4 0.0001
568 CARDIOGENIC SHOCK 2 0.0001
569 IMPAIRED QUALITY OF LIFE 2 0.0001
570 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
571 DERMATITIS BULLOUS 1 0.0001
572 CONSTIPATION 30 0.0001
573 APATHY 2 0.0001
574 ANAEMIA 26 0.0001
575 BLINDNESS TRANSIENT 1 0.0001
576 BLOOD PRESSURE DECREASED 9 0.0001
577 ARTHROPOD BITE 1 0.0001
578 COLON CANCER 2 0.0001
579 CARDIAC ARREST 11 0.0001
580 CHROMATURIA 3 0.0001
581 BREAST TENDERNESS 1 0.0001
582 HEART RATE IRREGULAR 3 0.0001
583 VOMITING 62 0.0001
584 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
585 HEPATOCELLULAR CARCINOMA 1 0.0001
586 OEDEMA PERIPHERAL 16 0.0001
587 HAEMODYNAMIC INSTABILITY 1 0.0001
588 ACIDOSIS 1 0.0001
589 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
590 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
591 PNEUMONIA 42 0.0001
592 HAEMOLYSIS 1 0.0001
593 ATRIOVENTRICULAR BLOCK 1 0.0001
594 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
595 URINARY TRACT INFECTION 22 0.0001
596 APHTHOUS ULCER 1 0.0001
597 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
598 HYPOALBUMINAEMIA 1 0.0001
599 ACUTE MYELOID LEUKAEMIA 2 0.0001
600 NERVOUS SYSTEM DISORDER 4 0.0001
601 HAEMORRHAGIC STROKE 1 0.0001
602 AFFECTIVE DISORDER 1 0.0001
603 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
604 FURUNCLE 1 0.0001
605 BLOOD ALBUMIN DECREASED 1 0.0001
606 SENSORY DISTURBANCE 2 0.0001
607 BLOOD POTASSIUM INCREASED 2 0.0001
608 CEREBRAL INFARCTION 3 0.0001
609 ENCEPHALOPATHY 3 0.0001
610 ABNORMAL FAECES 1 0.0001
611 DYSPEPSIA 12 0.0001
612 METASTASES TO BONE 2 0.0001
613 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
614 CYTOMEGALOVIRUS INFECTION 2 0.0001
615 EOSINOPHIL COUNT INCREASED 1 0.0001
616 DEHYDRATION 16 0.0001
617 CARDIO-RESPIRATORY ARREST 5 0.0001
618 BLOOD UREA INCREASED 2 0.0001
619 HAEMODIALYSIS 1 0.0001
620 DRUG USE DISORDER 1 0.0001
621 INFUSION SITE ERYTHEMA 1 0.0001
622 FACE OEDEMA 2 0.0001
623 CANDIDA INFECTION 2 0.0001
624 DIABETES MELLITUS 9 0.0001
625 HAEMATURIA 4 0.0001
626 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
627 INFLAMMATION 6 0.0001
628 BLOOD CALCIUM INCREASED 1 0.0001
629 COLD SWEAT 2 0.0001
630 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
631 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
632 PLATELET COUNT DECREASED 12 0.0001
633 GASTROINTESTINAL INFECTION 1 0.0001
634 ANAL INCONTINENCE 1 0.0001
635 HEAVY MENSTRUAL BLEEDING 1 0.0001
636 ACUTE KIDNEY INJURY 17 0.0001
637 BLOOD BILIRUBIN INCREASED 3 0.0001
638 DEVELOPMENTAL DELAY 1 0.0001
639 PALLOR 3 0.0001
640 PNEUMONITIS 3 0.0001
641 GASTROINTESTINAL CARCINOMA 1 0.0001
642 PANIC ATTACK 4 0.0001
643 RESPIRATORY ARREST 3 0.0001
644 TINNITUS 5 0.0001
645 COVID-19 19 0.0001
646 BRONCHITIS 8 0.0001
647 CONJUNCTIVITIS 2 0.0001
648 AGRANULOCYTOSIS 2 0.0001
649 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
650 HEPATIC STEATOSIS 2 0.0001
651 DEMENTIA 3 0.0001
652 THINKING ABNORMAL 2 0.0001
653 BLOOD CHOLESTEROL INCREASED 5 0.0001
654 ERYTHEMA MULTIFORME 1 0.0001
655 HAEMOGLOBIN DECREASED 11 0.0001
656 DIARRHOEA HAEMORRHAGIC 1 0.0001
657 ABDOMINAL PAIN UPPER 22 0.0001
658 HEPATIC CIRRHOSIS 2 0.0001
659 FRACTURE 2 0.0001
660 DYSPHAGIA 10 0.0001
661 EYE INFLAMMATION 1 0.0001
662 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
663 SEROTONIN SYNDROME 2 0.0001
664 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
665 ACUTE RESPIRATORY FAILURE 2 0.0001
666 HYPERCHOLESTEROLAEMIA 1 0.0001
667 EAR PAIN 2 0.0001
668 SKIN FISSURES 2 0.0001
669 KIDNEY INFECTION 2 0.0001
670 BODY TEMPERATURE DECREASED 1 0.0001
671 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
672 HYPOTONIA 1 0.0001
673 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
674 CYTOKINE RELEASE SYNDROME 2 0.0001
675 APHASIA 3 0.0001
676 STOMATITIS 6 0.0001
677 BONE MARROW FAILURE 2 0.0001
678 EPILEPSY 3 0.0001
679 EAR DISCOMFORT 1 0.0001
680 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
681 OSTEOPOROSIS 4 0.0001
682 FOLLICULITIS 1 0.0001
683 MOUTH ULCERATION 2 0.0001
684 FULL BLOOD COUNT ABNORMAL 1 0.0001
685 METABOLIC ACIDOSIS 3 0.0001
686 JOINT INJURY 2 0.0001
687 BODY HEIGHT DECREASED 1 0.0001
688 LIVER FUNCTION TEST INCREASED 2 0.0001
689 BLOOD CREATININE INCREASED 6 0.0001
690 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
691 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
692 MALAISE 40 0.0001
693 GASTROINTESTINAL PAIN 1 0.0001
694 TOOTH DISORDER 2 0.0001
695 HEPATOTOXICITY 2 0.0001
696 GAIT INABILITY 3 0.0001
697 THROMBOCYTOPENIA 10 0.0001
698 GLOSSODYNIA 2 0.0001
699 ORAL PAIN 2 0.0001
700 GASTROINTESTINAL DISORDER 8 0.0001
701 FISTULA 1 0.0001
702 BLOOD CALCIUM DECREASED 1 0.0001
703 DERMATITIS CONTACT 1 0.0001
704 WEIGHT DECREASED 24 0.0001
705 BURNING SENSATION 6 0.0001
706 LYMPHADENOPATHY 3 0.0001
707 COVID-19 PNEUMONIA 1 0.0001
708 TREMOR 14 0.0001
709 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
710 PRODUCTIVE COUGH 4 0.0001
711 DIARRHOEA 54 0.0001
712 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
713 DRUG INTOLERANCE 8 0.0001
714 ADRENAL INSUFFICIENCY 1 0.0001
715 NEURALGIA 2 0.0001
716 UNDERDOSE 6 0.0001
717 BACK PAIN 19 0.0001
718 HYPERCALCAEMIA 1 0.0001
719 ABASIA 2 0.0001
720 NEUTROPENIA 11 0.0001
721 OSTEONECROSIS OF JAW 2 0.0001
722 INFLUENZA 9 0.0001
723 CYST 1 0.0001
724 EXTRAPYRAMIDAL DISORDER 2 0.0001
725 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
726 HYPERTENSION 17 0.0001
727 MUSCULAR WEAKNESS 9 0.0001
728 BRAIN OEDEMA 1 0.0001
729 ABDOMINAL PAIN LOWER 2 0.0001
730 HAEMATEMESIS 2 0.0001
731 HYPOPHAGIA 2 0.0001
732 HEPATITIS 2 0.0001
733 SEIZURE 9 0.0001
734 ANAPHYLACTIC SHOCK 2 0.0001
735 INJECTION SITE INDURATION 1 0.0001
736 ANHEDONIA 2 0.0001
737 WEIGHT INCREASED 17 0.0001
738 DISORIENTATION 3 0.0001
739 DEPRESSED MOOD 4 0.0001
740 DYSMENORRHOEA 1 0.0001
741 BRADYCARDIA 4 0.0001
742 ADVERSE REACTION 1 0.0001
743 HAIR TEXTURE ABNORMAL 1 0.0001
744 AKATHISIA 1 0.0001
745 RESPIRATORY DISTRESS 2 0.0001
746 ABNORMAL DREAMS 2 0.0001
747 POLLAKIURIA 3 0.0001
748 ATRIAL FIBRILLATION 7 0.0001
749 PANCYTOPENIA 4 0.0001
750 CARPAL TUNNEL SYNDROME 1 0.0001
751 DEVICE OCCLUSION 1 0.0001
752 BRONCHOSPASM 1 0.0001
753 SYNCOPE 7 0.0001
754 RED BLOOD CELL COUNT DECREASED 2 0.0001
755 MOBILITY DECREASED 5 0.0001
756 LETHARGY 4 0.0001
757 HYPOKINESIA 1 0.0001
758 NEEDLE ISSUE 2 0.0001
759 NAUSEA 54 0.0001
760 AGITATION 5 0.0001
761 CONFUSIONAL STATE 11 0.0001
762 RENAL FAILURE 9 0.0001
763 LABORATORY TEST ABNORMAL 2 0.0001
764 TACHYCARDIA 6 0.0001
765 CATARACT 4 0.0001
766 HAEMORRHAGE INTRACRANIAL 1 0.0001
767 HOT FLUSH 5 0.0001
768 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
769 CORONARY ARTERY DISEASE 2 0.0001
770 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
771 ABDOMINAL DISCOMFORT 11 0.0001
772 INSURANCE ISSUE 1 0.0001
773 EMOTIONAL DISORDER 2 0.0001
774 ANKLE FRACTURE 1 0.0001
775 HALLUCINATION, AUDITORY 1 0.0001
776 ABSCESS 1 0.0001
777 CARDIAC FAILURE 5 0.0001
778 CARDIAC FAILURE CONGESTIVE 5 0.0001
779 LACTIC ACIDOSIS 2 0.0001
780 SWELLING FACE 4 0.0001
781 ASTHENIA 23 0.0001
782 EYE DISORDER 2 0.0001
783 HEART RATE INCREASED 6 0.0001
784 VISUAL ACUITY REDUCED 2 0.0001
785 VIRAL INFECTION 2 0.0001
786 INSOMNIA 16 0.0001
787 COAGULOPATHY 1 0.0001
788 FUNGAL INFECTION 2 0.0001
789 CHILLS 7 0.0001
790 CELLULITIS 3 0.0001
791 RENAL IMPAIRMENT 5 0.0001
792 HEMIPARESIS 1 0.0001
793 ILLNESS 6 0.0001
794 DELIRIUM 2 0.0001
795 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
796 EOSINOPHILIA 1 0.0001
797 DRUG INTERACTION 9 0.0001
798 LYMPHOCYTE COUNT DECREASED 1 0.0001
799 HEAD DISCOMFORT 1 0.0001
800 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
801 DIZZINESS 28 0.0001
802 OFF LABEL USE 49 0.0001
803 CEREBRAL HAEMORRHAGE 2 0.0001
804 GOUT 1 0.0001
805 DISTURBANCE IN ATTENTION 3 0.0001
806 MYELOSUPPRESSION 2 0.0001
807 END STAGE RENAL DISEASE 1 0.0001
808 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
809 RESTLESSNESS 2 0.0001
810 URTICARIA 9 0.0001
811 BACTERIAL INFECTION 1 0.0001
812 CARDIAC DISORDER 5 0.0001
813 BLOOD SODIUM DECREASED 1 0.0001
814 MYALGIA 9 0.0001
815 HYPOCALCAEMIA 1 0.0001
816 MIGRAINE 5 0.0001
817 HERNIA 1 0.0001
818 DYSTONIA 1 0.0001
819 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
820 HAEMORRHOIDS 1 0.0001
821 CHOKING 1 0.0001
822 FALL 17 0.0001
823 WHEEZING 3 0.0001
824 DISABILITY 1 0.0001
825 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
826 ABNORMAL BEHAVIOUR 2 0.0001
827 HAEMATOCRIT DECREASED 1 0.0001
828 FULL BLOOD COUNT DECREASED 1 0.0000
829 DYSKINESIA 2 0.0000
830 BLINDNESS 2 0.0000
831 FATIGUE 38 0.0000
832 INJECTION SITE WARMTH 1 0.0000
833 VISUAL IMPAIRMENT 6 0.0000
834 BLOOD GLUCOSE INCREASED 9 0.0000
835 DERMATITIS 1 0.0000
836 HALLUCINATION, VISUAL 1 0.0000
837 PAIN 29 0.0000
838 OSTEOARTHRITIS 2 0.0000
839 GAIT DISTURBANCE 9 0.0000
840 LOSS OF CONSCIOUSNESS 6 0.0000
841 HYPERHIDROSIS 6 0.0000
842 HYPOACUSIS 2 0.0000
843 BALANCE DISORDER 4 0.0000
844 DEEP VEIN THROMBOSIS 3 0.0000
845 MENTAL DISORDER 2 0.0000
846 DYSPNOEA 26 0.0000
847 INTENTIONAL PRODUCT MISUSE 4 0.0000
848 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
849 ASTHMA 5 0.0000
850 PRURITUS 17 0.0000
851 HEPATIC ENZYME INCREASED 3 0.0000
852 ERYTHEMA 9 0.0000
853 VISION BLURRED 6 0.0000
854 NEPHROLITHIASIS 2 0.0000
855 SKIN DISCOLOURATION 2 0.0000
856 COGNITIVE DISORDER 2 0.0000
857 COUGH 12 0.0000
858 SLEEP DISORDER 3 0.0000
859 DISEASE PROGRESSION 5 0.0000
860 ANXIETY 12 0.0000
861 PULMONARY EMBOLISM 4 0.0000
862 SKIN BURNING SENSATION 3 0.0000
863 BLOOD PRESSURE FLUCTUATION 1 0.0000
864 DIABETIC KETOACIDOSIS 1 0.0000
865 CONTUSION 4 0.0000
866 INFECTION 6 0.0000
867 ARTHRALGIA 17 0.0000
868 LUNG DISORDER 2 0.0000
869 DYSGEUSIA 3 0.0000
870 AGGRESSION 2 0.0000
871 SOMNOLENCE 8 0.0000
872 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
873 GASTRIC CANCER 1 0.0000
874 CONDITION AGGRAVATED 12 0.0000
875 CARDIOVASCULAR DISORDER 1 0.0000
876 BLOOD PRESSURE INCREASED 6 0.0000
877 PERIPHERAL SWELLING 6 0.0000
878 DRUG RESISTANCE 1 0.0000
879 DIPLOPIA 1 0.0000
880 HAEMORRHAGE 4 0.0000
881 DEAFNESS 1 0.0000
882 MUSCULOSKELETAL PAIN 2 0.0000
883 MUSCLE SPASMS 7 0.0000
884 NASOPHARYNGITIS 7 0.0000
885 CHEST PAIN 7 0.0000
886 HYPERSENSITIVITY 7 0.0000
887 FEELING ABNORMAL 9 0.0000
888 DRY SKIN 5 0.0000
889 DRY MOUTH 3 0.0000
890 MEMORY IMPAIRMENT 5 0.0000
891 ANAPHYLACTIC REACTION 2 0.0000
892 DIVERTICULITIS 1 0.0000
893 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
894 BLISTER 2 0.0000
895 OXYGEN SATURATION DECREASED 2 0.0000
896 EYE PAIN 2 0.0000
897 CEREBROVASCULAR ACCIDENT 6 0.0000
898 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
899 CONVULSION 2 0.0000
900 HYPOTENSION 7 0.0000
901 HERPES ZOSTER 2 0.0000
902 EYE IRRITATION 2 0.0000
903 DYSSTASIA 1 0.0000
904 DYSPHONIA 2 0.0000
905 BONE PAIN 2 0.0000
906 PAIN IN EXTREMITY 10 0.0000
907 ACUTE MYOCARDIAL INFARCTION 1 0.0000
908 HEADACHE 21 0.0000
909 HYPOAESTHESIA 5 0.0000
910 BLOOD POTASSIUM DECREASED 1 0.0000
911 THERAPEUTIC RESPONSE DECREASED 2 0.0000
912 VERTIGO 2 0.0000
913 DISCOMFORT 2 0.0000
914 FEELING HOT 2 0.0000
915 DRUG ADMINISTRATION ERROR 1 0.0000
916 HOSPITALISATION 5 0.0000
917 OVERDOSE 7 0.0000
918 OROPHARYNGEAL PAIN 3 0.0000
919 FEMUR FRACTURE 1 0.0000
920 INJECTION SITE ERYTHEMA 4 0.0000
921 RASH 14 0.0000
922 SWELLING 3 0.0000
923 BONE DENSITY DECREASED 1 0.0000
924 CYSTITIS 1 0.0000
925 HYPOTHYROIDISM 1 0.0000
926 RHINORRHOEA 2 0.0000
927 DEPRESSION 7 0.0000
928 EXPIRED PRODUCT ADMINISTERED 1 0.0000
929 LIP SWELLING 1 0.0000
930 NEOPLASM MALIGNANT 2 0.0000
931 ANGER 1 0.0000
932 CHEST DISCOMFORT 3 0.0000
933 GASTRIC DISORDER 1 0.0000
934 HEART RATE DECREASED 1 0.0000
935 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
936 CRYING 1 0.0000
937 ACCIDENTAL OVERDOSE 1 0.0000
938 PRODUCT DOSE OMISSION ISSUE 8 0.0000
939 DYSURIA 1 0.0000
940 EYE SWELLING 1 0.0000
941 EPISTAXIS 2 0.0000
942 DYSARTHRIA 1 0.0000
943 HALLUCINATION 2 0.0000
944 UNEVALUABLE EVENT 2 0.0000
945 ACNE 2 0.0000
946 INJECTION SITE PAIN 8 0.0000
947 DRUG INEFFECTIVE 34 0.0000
948 ARTHRITIS 2 0.0000
949 THROMBOSIS 2 0.0000
950 EMOTIONAL DISTRESS 3 0.0000
951 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
952 DEVICE BREAKAGE 1 0.0000
953 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
954 SKIN EXFOLIATION 2 0.0000
955 DEVICE LEAKAGE 1 0.0000
956 DEVICE DISLOCATION 1 0.0000
957 PSORIASIS 3 0.0000
958 MUSCULOSKELETAL STIFFNESS 2 0.0000
959 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
960 COLITIS ULCERATIVE 1 0.0000
961 PRODUCT QUALITY ISSUE 3 0.0000
962 BREAST CANCER 2 0.0000
963 PRODUCT USE ISSUE 4 0.0000
964 NEUROPATHY PERIPHERAL 2 0.0000
965 COMA 1 0.0000
966 DEATH 17 0.0000
967 FLUSHING 2 0.0000
968 ECZEMA 1 0.0000
969 PARAESTHESIA 3 0.0000
970 TOXICITY TO VARIOUS AGENTS 3 0.0000
971 RHEUMATOID ARTHRITIS 2 0.0000
972 MYOCARDIAL INFARCTION 3 0.0000
973 PALPITATIONS 2 0.0000
974 IRRITABILITY 1 0.0000
975 EXPOSURE DURING PREGNANCY 1 0.0000
976 AMNESIA 1 0.0000
977 INFUSION RELATED REACTION 1 0.0000
978 INJECTION SITE REACTION 1 0.0000
979 CHRONIC KIDNEY DISEASE 1 0.0000
980 INJECTION SITE SWELLING 1 0.0000
981 COMPLETED SUICIDE 1 0.0000
982 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
983 DRUG WITHDRAWAL SYNDROME 1 0.0000
984 DEVICE ISSUE 1 0.0000
985 ADVERSE EVENT 1 0.0000
986 ALOPECIA 2 0.0000
987 INCORRECT DOSE ADMINISTERED 2 0.0000
988 JOINT SWELLING 1 0.0000
989 DRUG DEPENDENCE 1 0.0000